戻る Agenda
Session 10 Track E: MSL Technology
Session Chair(s)
Kevin Charles Henderson, PHARMD, MBA
Executive Director, Hematology US Medical Affairs
Gilead Sciences, United States
The MSL technology session is a broad-based overview of various technology applications and programs currently utilized by pharmaceutical/biotechnology companies. MSL representatives from these companies will review these tools in terms of how they are utilized to support the MSL function. Highlights of these presentations will involve interactive discussions with the presenters on real-world experiences with these applications, including what worked well and also lessons learned.
Learning Objective : At the conclusion of this session, participants should be able to:
• Describe various means of utilizing technology to support and execute MSL core responsibilities and field-based activities
• Understand the future direction of business process technology development within the pharmaceutical/biotechnology industry and its application to the MSL role
Speaker(s)
Faculty
Paul Latimer, PHD
Genentech, Inc., A Member of the Roche Group, United States
Medical Science Liaison
Faculty
Kimberly Boothe, PHARMD, MHA
Yale New Haven Hospital, United States
Director, Pharmacy
Faculty
Kevin Chan, PHARMD
Bayer HealthcarePharmaceuticals, United States
Rutgers Postdoctoral Fellow
Faculty
Gary Takher
Sanofi US, United States
Regional Medical Liaison